Stemedica Cell Technologies Inc.
Edit Page
Report
Scan day: 17 February 2014 UTC
29
Virus safety - good
Description: Biopharmaceutical company developing adult stem cell products for current pre-clinical and future clinical studies in the United States and for on-going pre-clinical and clinical studies internationally.
Stemedica announced today that Richard Mejia, Jr. has joined the Company’s Board of Directors and will be Chairman of the Company’s Audit Committee effective January 31, 2014. Stemedica announced today that Craig W. Carlson has been appointed the Company’s Chief Financial Officer effective March, 2014.
Size: 309 chars
Contact Information
Email: —
Phone&Fax: 858 658 0910
Address: —
Extended: —
WEBSITE Info
| Page title: | Stemedica - Home |
| Keywords: | Stemedica, adult stem cells, stem cell, stem cells, stem cell research, clinical trial |
| Description: | Stemedica is a biopharmaceutical company that develops and manufactures adult stem cell products for use in clinical and pre-clinical trials. Currently within the USA the research activities are pre-clinical. Internationally we have clinical and pre-clinical studies |
| IP-address: | 64.251.198.62 |
WHOIS Info
| NS | Name Server: NS.SERVERCONCEPTS.COM Name Server: NS2.SERVERCONCEPTS.COM |
| WHOIS | Status: clientDeleteProhibited Status: clientRenewProhibited Status: clientTransferProhibited Status: clientUpdateProhibited |
| Date | Creation Date: 24-jun-2005 Expiration Date: 24-jun-2015 |